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Abstract
Background: Low-frequency nonsyndromic hearing loss (LF-NSHL) is a rare, inherited disorder. Here, we report a
family with LF-NSHL in whom a missense mutation was found in the Wolfram syndrome 1 (WFS1) gene.
Case presentation: Family members underwent audiological and imaging evaluations, including pure tone
audiometry and temporal bone computed tomography. Blood samples were collected from two affected and two
unaffected subjects. To determine the genetic background of hearing loss in this family, genetic analysis was
performed using whole-exome sequencing. Among 553 missense variants, c.2419A→ C (p.Ser807Arg) in WFS1
remained after filtering and inspection of whole-exome sequencing data. This missense mutation segregated with
affected status and demonstrated an alteration to an evolutionarily conserved amino acid residue. Audiological
evaluation of the affected subjects revealed nonprogressive LF-NSHL, with early onset at 10 years of age, but not to a
profound level.
Conclusion: This is the second report to describe a pathological mutation in WFS1 among Korean patients and the
second to describe the mutation in a different ethnic background. Given that the mutation was found in independent
families, p.S807R possibly appears to be a “hot spot” in WFS1, which is associated with LF-NSHL.
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Background
Hearing loss is a common sensory disorder in humans
and is caused by genetic mutations in more than 60% of
cases. According to the Hereditary Hearing Loss
Homepage (http://hereditaryhearingloss.org), autosomal
dominant, nonsyndromic hearing loss is known to be
associated with 59 genetic loci. Among these loci, which
are designated DFNA (DFN = deafness; A = dominant),
DFNA6, DFNA14, and DFNA38 are associated with low-
frequency nonsyndromic sensorineural hearing loss (LF-
NSHL) and caused by a heterozygous mutation in the
Wolfram syndrome 1 (WFS1) gene [1, 2].
WFS1 is located on human chromosome 4p16.1, and
the eight exons of WFS1 encode a transmembrane
protein. Exon 1 is noncoding, and exon 8 is the largest,
containing 2.6 kb of DNA. Most mutations in WFS1
have been identified in exon 8 and, moreover, in exons
3, 4, 5, and 6–8. The WFS1 gene encodes wolframin, an
890-amino acid protein with an estimated molecular
mass of 100 kDa. Wolframin is abundantly expressed in
the pancreas, brain, heart, and muscle and is a
hydrophobic and tetrameric protein with nine
transmembrane domains and large hydrophilic regions
at both ends [3, 4]. Mutations in WFS1 are associated
with autosomal recessive Wolfram syndrome and the
autosomal dominant type of LF-NSHL (DFNA6/14/38).
Wolfram syndrome has been identified in patients with
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diabetes insipidus, diabetes mellitus, optic atrophy, and
hearing loss [5].
Using whole-exome sequencing (WES), we examined a
Korean family (Yonsei University Hearing Loss [YUHL]
30) and identified a missense mutation, c.2419A→ C
(p.Ser807Arg), in the WFS1 gene. In members of the
pedigree, the mutation led to nonsyndromic autosomal
dominant, symmetrically bilateral hearing loss at low-to-
mid frequencies.
Case presentation
With approval from the Institutional Review Board of
the Severance Hospital, Yonsei University (Seoul,
South Korea) Health System (IRB#4–2015-0659), sub-
jects with inherited hearing loss were enrolled in the
YUHL cohort. After obtaining written informed con-
sent, two affected and two unaffected subjects in the
YUHL30 family were investigated. The pedigree of
the YUHL30 family is shown in Fig. 1a. All affected
subjects exhibited sensorineural hearing loss but no
other syndromic phenotypes. The blood sugar levels
of the subjects were within the normal range, and no
subjects showed clinical symptoms suggesting diabetes
mellitus or insipidus. In addition, the affected subjects
had normal vision and no optic atrophy in ophthal-
mic evaluations. The proband 30–22 exhibited non-
syndromic autosomal dominant hearing loss at low-
to-mid frequencies, of which the pure-tone threshold
averages of 500, 1000, 2000, and 4000 Hz were 41
and 36 dB HL in the right and left ears, respectively
(Fig. 1b). The hearing loss was symmetrically bilateral
and was mild to moderate in severity. In speech
audiometry, the word recognition score was 100% for
both ears. In impedance audiometry, both drums were
type A (compliance was 0.5 cm for both ears). In
temporal bone CT scans, there were no inner ear
anomalies or middle ear deformities (Fig. 1c). The
mother of subject 30–22 (30–12) was also affected
and exhibited a moderate level of bilateral sensori-
neural hearing loss at low-to-mid frequencies. The
onset of hearing loss occurred at approximately
10 years of age in both subjects (30–22 and 30–12).
While hearing function at frequencies between 2000
and 8000 Hz was well preserved, the hearing thresh-
old was increased up to 50–60 dB HL at frequencies
of 2000 Hz or less in the two affected subjects.
Notably, it did not appear that hearing loss was
progressive, since 30–12 (45 years of age) exhibited a
degree and pattern of hearing loss similar to 30–22
(14 years of age).
To identify the genetic cause of hearing loss in this
family, WES was performed for 30–22, from whom
DNA samples were available. DNA preparation, WES,
sequence alignment, and variant calling were performed
as previously reported [6]. Based on the pedigree and
the fact that the affected individuals were a parent and
her child, autosomal dominant hearing loss was assumed
(Fig. 1a). There were 622 variants which were
Fig. 1 Pedigree and audiological evaluation. a Pedigree of the family (Yonsei University Hearing Loss [YUHL] 30 family) is shown. Affected individuals
are denoted by gray symbols, males are denoted by squares, and females are denoted by circles. The affected proband (30–22) was a 14-year-old fe-
male with low-to-mid frequency nonsyndromic hearing loss. b Pure-tone audiometry of the subjects is depicted. Frequencies (Hz) were plotted on the
x-axis and the auditory threshold in decibels (dB HL) was plotted on the y-axis. Red circles refer to the right ear, and blue crosses refer to the left ear
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nonsynonymous or located in a splice site; a variant in
WFS1 (c.2419A→ C; p.Ser807Arg) remained after filter-
ing and inspection of WES data (Tables 1 and 2). This
variant was a missense mutation and not found in public
databases, such as dbSNP (http://www.ncbi.nlm.nih.gov/
projects/SNP/) or gnomAD, for the affected status. Add-
itionally, this mutation was associated with an alteration
in an amino acid residue that has been well
conserved throughout evolution from Mus musculus,
Gallus gallus, Xenopus tropicalis, and Danio rerio
(Table 2, Fig. 2a, b). Mutations in WFS1 are known
to cause autosomal dominant deafness (MIM 600965)
[7]. The p.S807R mutation has been reported once in
the United Kingdom but not in other counties,
including Korea [7].
Discussion and conclusions
In the present study, we used WES to successfully
identify a mutation in WFS1 causing the autosomal
dominant type of sensorineural hearing loss.
To date, more than 250 mutations in the WFS1 gene
have been reported worldwide (http://www.hgmd.cf.a-
c.uk/ac/index.php). Mutations in the WFS1 gene are
responsible for both Wolfram syndrome and autosomal
dominant, nonsyndromic hearing loss (DFNA6/14/38)
[1, 8, 9]. Wolfram syndrome is an autosomal recessive
type disorder associated with diabetes mellitus, diabetes
insipidus, optic atrophy, and hearing loss. In
nonsyndromic hearing loss, DFNA6/14/38 leads to LF-
NSHL. According to the literature, there are two known
genes responsible for low-frequency hearing loss:
DIAPH1 and WFS1 [7]. Mutations in DIAPH1 lead to
progressive hearing loss and profound bilateral deafness
involving all frequencies. However, mutations in WFS1
cause progressive hearing loss, but only at low frequen-
cies and not until profound hearing loss in the case of
nonsyndromic hearing loss [10, 11]. In the present study,
p.S807R was also associated with LF-NSHL, with moder-
ate severity at 60 dB HL. This audiological feature is
unique only in hearing loss associated with mutations in
WFS1; thus, screening of WFS1 is a reasonable first step
in cases of suspected LF-NSHL without progression to a
profound level.
Our description of the p.S807R (c.2419A→C)
mutation in WFS1 is the second report of a mutation
associated with LF-NSHL in Korean patients; the first
report was the p.V412A mutation in WFS1 [12].
Table 1 Filtering process of whole exome sequencing analysis
in this study
Patient (30–22)
Total sequence reads 93,205,604
Matched Reads (percentage of reads) 91,298,272 (97.95%)
Total number of variants detected 187,202
Variants which are not common
dbSNP138 (MAF > 1%) (A)
37,206
Variants which are not present in
32 control of healthy individuals
9487
Variants which are nonsynonymous
or located in splice junction (B)
622
% B / A 1.67%
Located within splice site 31
Deletion/Insertion 33




SNPs after inspection of MAF
< 0.05% & amino acid conservation
168
Located within splice site 7
Deletion/Insertion 3
Stop codon gained / Stop codon lost 5
Missense 153
Variant in 129 genes known to deafness
genes
4
Sanger confirmation / Segregation 2
Causative mutation WFS1













dbSNPc gnomADd PP2e MTf PROVEANg SIFTh
WFS1 30–22 F c.2419A >
C












Dam damaging, DC disease causing, Del deleterious; het, heterozygous in affected individual, MAF minor allele frequency, F Female, Mo heterozygous mutation
identified in mother, ND no data or DNA available, SNP single nucleotide polymorphism, D. rerio Danio rerio, G. galllus Gallus gallus, M. musculus Mus musculus,
X.tropicalis Xenopus tropicalis
aComplementary DNA (cDNA) mutations are numbered according to human cDNA reference sequence NM_006005.3 (WFS1);
bAmino acid residue is continually conserved throughout evolution, including the species indicated;
cdbSNP database (http://www.ncbi.nlm.nih.gov/SNP);
dgnomAD browser (gnomad.broadinstitute.org/);
ePolyPhen-2 (PP2) prediction score (HumVar), ranges from 0 to 1.0 (0 = benign, 1.0 = probably damaging [http://genetics.bwh.harvard.edu/pph2/]);
fMutation taster (http://www.mutationtaster.org/);
gProtein Variation Effect Analyzer (PROVEAN; http://provean.jcvi.org/index.php);
hSorting Intolerant from Tolerant (SIFT; http://sift.jcvi.org/)
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Although there are more than 250 mutations in
WFS1, some rare mutations have been identified in
multiple independent families. In addition, there are
only two mutations that span two different ethnic
backgrounds: European (p.A716T) and Japanese
(p.E864K) [10]. p.S807R was previously reported in a
family from the United Kingdom [8]; however, this
study is the first to identify and report the mutation
in an East-Asian individual. Interestingly, all muta-
tions found in both ethnicities (European and East
Asian, including p.A716T, p.E864K, and p.S807R) are
located in exon 8, which encodes the C-terminal
intracytoplasmic domain. This finding indicates that
these mutations may be “hot spot” mutations in exon
8 that span different ethnicities. To convincely tell
the mutation is a founder mutation (the result of ad-
mixture of two ethnics) or a hot spot, it would be
helpful to to compare haplotypes of our patients and
British patients.
The majority of mutations associated with LF-NSHL
are, in fact, missense mutations located in exon 8, whereas
those linked to Wolfram syndrome are frameshift and
nonsense mutations [7, 8, 10]. The mutations responsible
for LF-NSHL do not inactivate WFS1 and are presumed
to have a dominant-negative effect on the normal WFS1
protein, consistent with an autosomal dominant type of
inheritance. Because the S807 residue is located in the C-
terminal domain, the missense mutation at p.S807R
affects only a limited number of functions. Although
the physiological role of WFS1 in the inner ear
remains unknown, mutations, such as p.S807R, only
partially disrupt the function of WFS1; thus, hearing
loss may not necessarily progress to profound
deafness.
Mutations in WFS1 are associated with LF-NSHL.
Given that p.S807R was previously found in individuals
of European ethnicity, p.S807R may be a hot-spot muta-
tion in WFS1. Because the majority of mutations in
WFS1 associated with LF-NSHL are located in exon 8,
screening exon 8 should be considered first in genetic
analyses of patients with LF-NSHL.
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Fig. 2 A mutation in WFS1 identified using whole-exome sequencing. a Sanger sequencing traces of subjects 30–11, 30–12, 30–21, and 30–22. b Mul-
tiple sequence alignment of WFS1 among different species. p.S807 is well preserved among various species
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